Stay updated on Nusinersen Safety in SMA Clinical Trial
Sign up to get notified when there's something new on the Nusinersen Safety in SMA Clinical Trial page.

Latest updates to the Nusinersen Safety in SMA Clinical Trial page
- Check7 days agoChange DetectedThis update adds: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, and removes Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows a new revision label 'Revision: v3.3.4' and removes the previous 'Revision: v3.3.3'. There are no observed changes to core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedA consolidated Locations section is added, listing sites in California, Connecticut, Maryland, Minnesota, Texas, and Washington, while individual state location headings were removed. The page revision updated to version 3.3.3.SummaryDifference0.7%

- Check72 days agoChange DetectedMinor editorial updates were added: a PubMed auto-fill note indicating publications may be sourced from PubMed and the revision label updated to v3.3.2, while the older wording and revision v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedA general government funding/operating status banner was removed from the page. The study title, design, eligibility criteria, contacts, and locations remain unchanged.SummaryDifference0.3%

- Check93 days agoChange DetectedNo substantial changes were detected in the study details, design, eligibility criteria, or outcomes; the update appears to be minor formatting adjustments and a revised timestamp.SummaryDifference0.4%

Stay in the know with updates to Nusinersen Safety in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nusinersen Safety in SMA Clinical Trial page.